and the new nonpeptide GLP-1, orforglipron (Foundayo)
Weight loss typically accelerates as the dose is gradually increased over 16 weeks to the maintenance dose of 2.4 mg weekly for weight management
In my experience reviewing the Phase 2 trial data, the appetite reduction is noticeable early, but the scale does not move much yet
Cost Plus Drugs built SwiftyRx, a software platform for pharmacy order management, as the technology layer that can plug into existing pharmacy distribution infrastructure
Enhancing stem cell function via culturing under hypoxic condition, which is known to prime MSCs to reduce cellular ROS levels, improved chondrogenic differentiation of MSCs [20] and cartilage regeneration in both post-traumatic and focal early OA rabbit models [21]
All animal experiments were approved by and conducted in compliance with Institutional Animal Care and Use Committee (IACUC) of the University of Colorado Anschutz Medical Campus